MedTrace Logo

Novel Strategies for Reducing Burn Scar Itch

NCT06801626 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2025-09-24

No results posted yet for this study

Summary

The purpose of the study is to see whether using diphenhydramine (Benadryl), famotidine (Pepcid), and cromolyn sodium will decrease burn scar itch.

Conditions

  • Burn Scar
  • Itch Scarring
  • Wound

Interventions

COMBINATION_PRODUCT

Famotidine and 4% topical cromolyn sodium

Patients will be instructed to take a 20mg famotidine capsule twice daily, and to use the lotion (4% cromolyn sodium) twice daily.

OTHER

Placebo

Treatment with active H1 antihistamine plus administration of placebo famotidine and placebo cromolyn sodium.

Sponsors & Collaborators

  • University of Texas

    collaborator OTHER

  • The University of Texas Medical Branch, Galveston

    lead OTHER

Principal Investigators

  • Celeste Finnerty, PhD · University of Texas Medical Branch, Galveston

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-01
Primary Completion
2026-12-31
Completion
2027-11-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06801626 on ClinicalTrials.gov